NCT04391712View on ClinicalTrials.gov

Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2020

Primary Completion Date

May 15, 2020

Study Completion Date

July 16, 2020

Conditions
COVID-19
Interventions
DEVICE

MLS Laser

Treatments will be delivered to the participants days 1-4, in a prone position using a 10 by 25 cm laser field across each lung with 7j/cm2 at 1500 Hz.

OTHER

Regular Inpatient Medical Care

Regular inpatient medical care

Trial Locations (1)

01854

Lowell General Hospital, Lowell

All Listed Sponsors
lead

Lowell General Hospital

OTHER

NCT04391712 - Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease | Biotech Hunter | Biotech Hunter